Next Article in Journal
Engineered Exosomes Carrying Super-Repressor IκB Reduced Biliary Atresia-Induced Liver Fibrosis in Minipig and Mouse Models
Next Article in Special Issue
High-Pressure Dielectric Spectroscopic Studies of Amorphous CBD: Investigating Molecular Dynamics and Physical Stability Under Manufacturing Conditions of the Pharmaceuticals
Previous Article in Journal
Flavonoids as Natural Anti-Inflammatory Agents in the Atopic Dermatitis Treatment
Previous Article in Special Issue
Co-Amorphous Solid Dispersion System for Improvement in Dissolution Profile of N-(((1r,4r)-4-((6-fluorobenzo[d]oxazol-2-yl)amino)cyclohexyl)methyl)-2-methylpropane-2-sulfonamide as a Neuropeptide Y5 Receptor Antagonist
 
 
Review

Article Versions Notes

Pharmaceutics 2025, 17(2), 262; https://doi.org/10.3390/pharmaceutics17020262
Action Date Notes Link
article xml file uploaded 16 February 2025 07:43 CET Original file -
article xml uploaded. 16 February 2025 07:43 CET Update https://www.mdpi.com/1999-4923/17/2/262/xml
article pdf uploaded. 16 February 2025 07:43 CET Version of Record https://www.mdpi.com/1999-4923/17/2/262/pdf
article html file updated 16 February 2025 07:45 CET Original file https://www.mdpi.com/1999-4923/17/2/262/html
Back to TopTop